(1)H NMR metabolomics analysis of renal cell carcinoma cells: Effect of VHL inactivation on metabolism
- PMID: 26620126
- DOI: 10.1002/ijc.29947
(1)H NMR metabolomics analysis of renal cell carcinoma cells: Effect of VHL inactivation on metabolism
Abstract
Von Hippel-Lindau (VHL) is an onco-suppressor involved in oxygen and energy-dependent promotion of protein ubiquitination and proteosomal degradation. Loss of function mutations of VHL (VHL-cells) result in organ specific cancers with the best studied example in renal cell carcinomas. VHL has a well-established role in deactivation of hypoxia-inducible factor (HIF-1) and in regulation of PI3K/AKT/mTOR activity. Cell culture metabolomics analysis was utilized to determined effect of VHL and HIF-1α or HIF-2α on metabolism of renal cell carcinomas (RCC). RCC cells were stably transfected with VHL or shRNA designed to silence HIF-1α or HIF-2α genes. Obtained metabolic data was analysed qualitatively, searching for overall effects on metabolism as well as quantitatively, using methods developed in our group in order to determine specific metabolic changes. Analysis of the effect of VHL and HIF silencing on cellular metabolic footprints and fingerprints provided information about the metabolic pathways affected by VHL through HIF function as well as independently of HIF. Through correlation network analysis as well as statistical analysis of significant metabolic changes we have determined effects of VHL and HIF on energy production, amino acid metabolism, choline metabolism as well as cell regulation and signaling. VHL was shown to influence cellular metabolism through its effect on HIF proteins as well as by affecting activity of other factors.
Keywords: HIF; NMR metabolomics; RCC; VHL; cancer metabolism; hypoxia; renal cancer.
© 2015 UICC.
Similar articles
-
Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.Oncogene. 2000 Nov 16;19(48):5435-43. doi: 10.1038/sj.onc.1203938. Oncogene. 2000. PMID: 11114720
-
Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.Cancer Res. 2006 Jun 15;66(12):6264-70. doi: 10.1158/0008-5472.CAN-05-2519. Cancer Res. 2006. PMID: 16778202
-
[The expression of hypoxia inducible factor-1,2 alpha in sporadic clear cell renal cell carcinoma and their relationships to the mutations of von Hippel-Lindau gene].Zhonghua Wai Ke Za Zhi. 2005 Mar 15;43(6):390-3. Zhonghua Wai Ke Za Zhi. 2005. PMID: 15854350 Chinese.
-
Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer.Eur Urol. 2016 Apr;69(4):646-657. doi: 10.1016/j.eururo.2015.08.007. Epub 2015 Aug 19. Eur Urol. 2016. PMID: 26298207 Free PMC article. Review.
-
VHL and HIF signalling in renal cell carcinogenesis.J Pathol. 2010 Jun;221(2):125-38. doi: 10.1002/path.2689. J Pathol. 2010. PMID: 20225241 Review.
Cited by
-
Metabolic consequences of HIF silencing in a triple negative human breast cancer xenograft.Oncotarget. 2018 Feb 24;9(20):15326-15339. doi: 10.18632/oncotarget.24569. eCollection 2018 Mar 16. Oncotarget. 2018. PMID: 29632647 Free PMC article.
-
Transcriptional alterations in hereditary and sporadic nonfunctioning pancreatic neuroendocrine tumors according to genotype.Cancer. 2018 Feb 1;124(3):636-647. doi: 10.1002/cncr.31057. Epub 2017 Nov 17. Cancer. 2018. PMID: 29149451 Free PMC article.
-
Preclinical Evaluation of Dimethyl Itaconate Against Hepatocellular Carcinoma via Activation of the e/iNOS-Mediated NF-κB-Dependent Apoptotic Pathway.Front Pharmacol. 2022 Jan 14;12:823285. doi: 10.3389/fphar.2021.823285. eCollection 2021. Front Pharmacol. 2022. PMID: 35095533 Free PMC article.
-
GOT1 regulates CD8+ effector and memory T cell generation.Cell Rep. 2023 Jan 31;42(1):111987. doi: 10.1016/j.celrep.2022.111987. Epub 2023 Jan 12. Cell Rep. 2023. PMID: 36640309 Free PMC article.
-
Uncovering the anticancer mechanism of Compound Kushen Injection against HCC by integrating quantitative analysis, network analysis and experimental validation.Sci Rep. 2018 Jan 12;8(1):624. doi: 10.1038/s41598-017-18325-7. Sci Rep. 2018. PMID: 29330507 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous